Jaerfaella, Sweden

Gunnar Hanshoff


Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 51(Granted Patents)


Location History:

  • Jaerfaella, SE (1980)
  • Jarfalla, SE (1977 - 1984)

Company Filing History:


Years Active: 1977-1984

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Gunnar Hanshoff

Introduction

Gunnar Hanshoff is a notable inventor based in Jaerfaella, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit thrombosis formation. With a total of 3 patents to his name, Hanshoff's work has the potential to impact medical treatments significantly.

Latest Patents

Hanshoff's latest patents include innovative compounds such as antifibrinolytically active derivatives of tranexamic acid. These novel compounds are designed to inhibit thrombosis and are described in detail in his patent filings. Another significant patent involves anti-thrombotic N-alkylthioakylamino benzenesulfonamides, which are new compounds that can be used in treating thrombosis and in fibronolytic therapy. The methods of producing these compounds involve complex chemical processes that build specific side chains from aromatic precursors.

Career Highlights

Throughout his career, Gunnar Hanshoff has worked with several companies, including Ab Kabi and Kabivitrum AB. His experience in these organizations has allowed him to refine his skills in pharmaceutical innovation and development. His contributions have been instrumental in advancing the field of thrombosis treatment.

Collaborations

Hanshoff has collaborated with notable colleagues such as Ferenc Merenyi and Lennart E Karlsson. These partnerships have fostered an environment of innovation and have led to the successful development of his patented compounds.

Conclusion

Gunnar Hanshoff's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations highlight his commitment to advancing medical treatments for thrombosis. His contributions are likely to have a lasting impact on the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…